Lexaria Bioscience Corp. (LEXX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.16M | -984.1K | -2.64M | -3.58M | -1.5M | -2.73M | -1.89M | -1.27M | -619.61K | -1.18M | -1.62M | -1.79M |
| Operating CF Margin % | -10819.36% | - | -1518.68% | -2059.74% | -860.86% | -1482.17% | -2251.97% | -1507.23% | -427.32% | -781.11% | 47237.98% | -2298.33% |
| Operating CF Growth % | -44.46% | 63.9% | -39.69% | -183.08% | -141.75% | -130.7% | -16.65% | 29.11% | 49.55% | 5.11% | -37.83% | -41.84% |
| Net Income | -1.45M | -1.6M | -2.7M | -3.79M | -2.72M | -2.71M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M |
| Depreciation & Amortization | 19.1K | 16.87K | 21.4K | 30.95K | 2.28K | 33.2K | -7.76K | 15.07K | 15.93K | 28.78K | 70.93K | 25.01K |
| Stock-Based Compensation | 74.89K | 74.89K | 122.72K | 470.14K | 167.22K | 99.42K | 96.51K | 341.77K | 0 | 53.95K | 9.63K | 81.45K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 9.27K | 22.02K | 234.54K | 49.64K | 17.85K | 16.12K | 32.03K | 85.06K | 26.54K | 55.2K | 261.63K | 11.1K |
| Working Capital Changes | -814.4K | 499.62K | -323.93K | -344.08K | 1.03M | -168.14K | 174.13K | 76.32K | -9.35K | -134.55K | -714.85K | 480.04K |
| Change in Receivables | 46.02K | 280.31K | -10.23K | -26.96K | -67.67K | -109.45K | 46.21K | 124.56K | 186.71K | -408.05K | -2.96K | -35.49K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.36K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -783.65K | 833.81K |
| Cash from Investing | -53.91K | -5.1K | -157.88K | -19.44K | -27.89K | -37.8K | -69.59K | -22K | -56.99K | -40.03K | -68.44K | -33.65K |
| Capital Expenditures | -40.82K | -5.1K | -1 | 1 | -1 | -24.64K | -43.01K | -22K | -56.99K | -40.03K | -68.44K | -33.65K |
| CapEx % of Revenue | 204.08% | - | 0% | 0% | 0% | 13.4% | 51.21% | 26.19% | 39.3% | 26.46% | -1993.5% | 43.3% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -13.09K | 0 | -157.88K | -19.44K | -27.89K | -13.16K | -26.57K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.04M | 3.47M | 0 | 1.69M | 11.72K | 4.35M | 0 | 5.04M | 3.45M | 1.82M | -121.69K | 1.71M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.04M | 3.47M | 0 | 1.69M | 11.72K | 4.35M | 0 | 0 | 2.96M | 1.25M | -121.69K | 1.71M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.04M | 491.82K | 571.65K | 0 | 0 |
| Net Change in Cash | 846.91K | 2.48M | -2.79M | -1.88M | -1.61M | 1.58M | -1.96M | 3.75M | 2.75M | 602.06K | -1.81M | -108.2K |
| Free Cash Flow | -2.22M | -989.2K | -2.66M | -3.6M | -1.53M | -2.76M | -1.96M | -1.29M | -676.6K | -1.22M | -1.69M | -1.82M |
| FCF Margin % | -11098.91% | - | -1527.07% | -2070.92% | -876.89% | -1502.72% | -2334.82% | -1533.43% | -466.62% | -807.57% | 49231.49% | -2341.63% |
| FCF Growth % | -45.48% | 64.21% | -35.48% | -179.75% | -125.51% | -126.23% | -16.04% | 29.21% | 46.34% | 4.57% | -37.78% | -40.28% |
| FCF per Share | -0.09 | -0.05 | -0.14 | -0.20 | -0.09 | -0.17 | -0.15 | -0.09 | -0.06 | -0.13 | -0.26 | -0.28 |
| FCF Conversion (FCF/Net Income) | 1.49x | 0.62x | 0.98x | 0.95x | 0.55x | 1.01x | 0.87x | 0.71x | 0.95x | 1.00x | 1.31x | 0.75x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 2.6K | 0 | 0 | 0 | 0 | 0 | -3.66K | 0 | 0 | 3.66K | 0 | 0 |